TrialHuman vaccines & immunotherapeutics2015

A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine.

Shashank Dalvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.